Analysts’ Updated EPS Estimates for April 28th (AGL, AMD, ARR, ARTL, ASUR, ATNM, ATO, AVTR, BA, BANC)

Analysts’ updated eps estimates for Monday, April 28th:

agilon health (NYSE:AGL) had its market perform rating reaffirmed by analysts at JMP Securities.

Advanced Micro Devices (NASDAQ:AMD) had its overweight rating reissued by analysts at Cantor Fitzgerald. They currently have a $180.00 target price on the stock.

ARMOUR Residential REIT (NYSE:ARR) was upgraded by analysts at Janney Montgomery Scott from a neutral rating to a buy rating.

Artelo Biosciences (NASDAQ:ARTL) had its buy rating reaffirmed by analysts at D. Boral Capital. The firm currently has a $6.00 target price on the stock.

Asure Software (NASDAQ:ASUR) had its outperform rating reaffirmed by analysts at Barrington Research. They currently have a $17.00 price target on the stock.

Actinium Pharmaceuticals (NYSE:ATNM) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $4.00 price target on the stock.

Atmos Energy (NYSE:ATO) was downgraded by analysts at Mizuho from an outperform rating to a neutral rating. The firm currently has $164.00 target price on the stock, down from their previous target price of $165.00.

Avantor (NYSE:AVTR) was downgraded by analysts at Stifel Nicolaus from a buy rating to a hold rating. The firm currently has $14.00 price target on the stock, down from their previous price target of $26.00.

Avantor (NYSE:AVTR) was downgraded by analysts at TD Cowen from a buy rating to a hold rating. They currently have $15.50 price target on the stock.

Boeing (NYSE:BA) was upgraded by analysts at Sanford C. Bernstein from a market perform rating to an outperform rating. Sanford C. Bernstein currently has $218.00 target price on the stock, up from their previous target price of $181.00.

Banc of California (NYSE:BANC) had its equal weight rating reissued by analysts at Stephens. Stephens currently has a $15.00 price target on the stock.

Brunswick (NYSE:BC) had its neutral rating reissued by analysts at DA Davidson. DA Davidson currently has a $43.00 target price on the stock, down from their previous target price of $64.00.

Bread Financial (NYSE:BFH) had its market perform rating reiterated by analysts at JMP Securities.

Berkshire Hills Bancorp (NYSE:BHLB) had its sector perform rating reiterated by analysts at Royal Bank of Canada. The firm currently has a $31.00 price target on the stock.

C&F Financial (NASDAQ:CFFI) was downgraded by analysts at StockNews.com from a buy rating to a hold rating.

Cognex (NASDAQ:CGNX) was upgraded by analysts at TD Cowen from a hold rating to a buy rating. TD Cowen currently has $35.00 target price on the stock.

CG Oncology (NASDAQ:CGON) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $75.00 price target on the stock.

CG Oncology (NASDAQ:CGON) had its overweight rating reaffirmed by analysts at Cantor Fitzgerald. The firm currently has a $75.00 price target on the stock.

Celestica (NYSE:CLS) (TSE:CLS) had its outperform rating reaffirmed by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $120.00 target price on the stock.

Comcast (NASDAQ:CMCSA) had its neutral rating reissued by analysts at Rosenblatt Securities. They currently have a $36.00 target price on the stock.

Chipotle Mexican Grill (NYSE:CMG) was downgraded by analysts at Argus from a buy rating to a hold rating.

Compass Therapeutics (NASDAQ:CMPX) had its buy rating reaffirmed by analysts at D. Boral Capital. The firm currently has a $32.00 target price on the stock.

Cinemark (NYSE:CNK) had its neutral rating reaffirmed by analysts at Wedbush. The firm currently has a $32.00 target price on the stock.

CONMED (NYSE:CNMD) was downgraded by analysts at Stifel Nicolaus from a buy rating to a hold rating. The firm currently has $55.00 target price on the stock, down from their previous target price of $75.00.

Coinbase Global (NASDAQ:COIN) had its sell rating reissued by analysts at Compass Point. Compass Point currently has a $180.00 target price on the stock.

Costco Wholesale (NASDAQ:COST) had its outperform rating reiterated by analysts at Telsey Advisory Group. Telsey Advisory Group currently has a $1,100.00 target price on the stock.

Coya Therapeutics (NASDAQ:COYA) had its buy rating reaffirmed by analysts at Chardan Capital. Chardan Capital currently has a $14.00 price target on the stock.

Custom Truck One Source (NYSE:CTOS) was downgraded by analysts at Robert W. Baird from an outperform rating to a neutral rating. They currently have $5.00 price target on the stock.

DoorDash (NASDAQ:DASH) had its market outperform rating reaffirmed by analysts at JMP Securities. JMP Securities currently has a $225.00 target price on the stock.

Digital Realty Trust (NYSE:DLR) had its market outperform rating reissued by analysts at JMP Securities. JMP Securities currently has a $220.00 target price on the stock.

Domino’s Pizza (NASDAQ:DPZ) had its buy rating reissued by analysts at TD Securities. The firm currently has a $490.00 price target on the stock.

Encompass Health (NYSE:EHC) had its buy rating reaffirmed by analysts at Truist Financial Co.. They currently have a $135.00 price target on the stock, up from their previous price target of $116.00.

Eastman Chemical (NYSE:EMN) had its neutral rating reissued by analysts at JPMorgan Chase & Co.. JPMorgan Chase & Co. currently has a $76.00 target price on the stock, down from their previous target price of $112.00.

Evolent Health (NYSE:EVH) had its market outperform rating reissued by analysts at JMP Securities. The firm currently has a $13.00 target price on the stock.

Floor & Decor (NYSE:FND) had its outperform rating reissued by analysts at Telsey Advisory Group. The firm currently has a $115.00 price target on the stock.

TechnipFMC (NYSE:FTI) had its outperform rating reiterated by analysts at Royal Bank of Canada. They currently have a $37.00 target price on the stock.

FuboTV (NYSE:FUBO) had its outperform rating reiterated by analysts at Wedbush. The firm currently has a $6.40 price target on the stock.

Heritage Commerce (NASDAQ:HTBK) had its overweight rating reiterated by analysts at Stephens. The firm currently has a $11.00 target price on the stock.

ImmunityBio (NASDAQ:IBRX) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $8.00 target price on the stock.

InMode (NASDAQ:INMD) had its hold rating reissued by analysts at Needham & Company LLC.

Kura Oncology (NASDAQ:KURA) had its buy rating reissued by analysts at HC Wainwright. They currently have a $40.00 price target on the stock.

Lazard (NYSE:LAZ) had its market outperform rating reissued by analysts at JMP Securities. JMP Securities currently has a $55.00 target price on the stock.

Medicus Pharma (NASDAQ:MDCX) had its buy rating reaffirmed by analysts at D. Boral Capital. They currently have a $14.00 price target on the stock.

Mondelez International (NASDAQ:MDLZ) had its outperform rating reiterated by analysts at Royal Bank of Canada. The firm currently has a $69.00 price target on the stock.

Merus (NASDAQ:MRUS) had its outperform rating reiterated by analysts at William Blair.

Newell Brands (NASDAQ:NWL) had its sector perform rating reiterated by analysts at Royal Bank of Canada. The firm currently has a $9.00 price target on the stock.

Olema Pharmaceuticals (NASDAQ:OLMA) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $30.00 price target on the stock.

Beigene (NASDAQ:ONC) had its outperform rating reaffirmed by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $312.00 target price on the stock.

Progressive (NYSE:PGR) was upgraded by analysts at Bank of America Co. from a neutral rating to a buy rating. They currently have $312.00 target price on the stock.

Privia Health Group (NASDAQ:PRVA) had its market outperform rating reaffirmed by analysts at JMP Securities. JMP Securities currently has a $29.00 target price on the stock.

Peloton Interactive (NASDAQ:PTON) was upgraded by analysts at Truist Financial Co. from a hold rating to a buy rating. The firm currently has $11.00 target price on the stock.

Reynolds Consumer Products (NASDAQ:REYN) had its sector perform rating reiterated by analysts at Royal Bank of Canada. The firm currently has a $30.00 target price on the stock.

Rio Tinto Group (NYSE:RIO) was downgraded by analysts at StockNews.com from a strong-buy rating to a buy rating.

Revolution Medicines (NASDAQ:RVMD) had its outperform rating reiterated by analysts at Wedbush. The firm currently has a $67.00 price target on the stock.

Rezolute (NASDAQ:RZLT) had its buy rating reissued by analysts at HC Wainwright. They currently have a $14.00 price target on the stock.

Saia (NASDAQ:SAIA) was downgraded by analysts at Bank of America Co. from a buy rating to a neutral rating. Bank of America Co. currently has $251.00 target price on the stock.

Summit Therapeutics (NASDAQ:SMMT) had its market outperform rating reiterated by analysts at JMP Securities. JMP Securities currently has a $40.00 price target on the stock.

SouthState (NASDAQ:SSB) had its overweight rating reaffirmed by analysts at Stephens. They currently have a $119.00 price target on the stock.

SpringWorks Therapeutics (NASDAQ:SWTX) had its neutral rating reaffirmed by analysts at Wedbush. Wedbush currently has a $47.00 price target on the stock, down from their previous price target of $81.00.

SpringWorks Therapeutics (NASDAQ:SWTX) had its equal weight rating reissued by analysts at Barclays PLC. They currently have a $47.00 target price on the stock, down from their previous target price of $63.00.

Protara Therapeutics (NASDAQ:TARA) had its buy rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $23.00 target price on the stock.

TriCo Bancshares (NASDAQ:TCBK) had its overweight rating reiterated by analysts at Stephens. They currently have a $47.00 price target on the stock.

Truist Financial (NYSE:TFC) was downgraded by analysts at StockNews.com from a hold rating to a sell rating.

Tri Pointe Homes (NYSE:TPH) was upgraded by analysts at Wedbush from a neutral rating to an outperform rating. The firm currently has $43.00 target price on the stock, up from their previous target price of $38.00.

Taysha Gene Therapies (NASDAQ:TSHA) had its market outperform rating reaffirmed by analysts at JMP Securities. They currently have a $5.00 target price on the stock.

Taysha Gene Therapies (NASDAQ:TSHA) had its overweight rating reaffirmed by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $7.00 target price on the stock.

UroGen Pharma (NASDAQ:URGN) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $55.00 target price on the stock.

UroGen Pharma (NASDAQ:URGN) had its buy rating reiterated by analysts at D. Boral Capital. They currently have a $25.00 price target on the stock.

Veritone (NASDAQ:VERI) had its buy rating reissued by analysts at D. Boral Capital. D. Boral Capital currently has a $4.50 target price on the stock.

VinFast Auto (NASDAQ:VFS) had its buy rating reaffirmed by analysts at Chardan Capital. Chardan Capital currently has a $5.50 price target on the stock, down from their previous price target of $13.00.

Viking Therapeutics (NASDAQ:VKTX) had its buy rating reiterated by analysts at Truist Financial Co.. They currently have a $75.00 target price on the stock, down from their previous target price of $95.00.

Valero Energy (NYSE:VLO) was upgraded by analysts at The Goldman Sachs Group, Inc. from a sell rating to a neutral rating. They currently have $127.00 target price on the stock, up from their previous target price of $115.00.

WSFS Financial (NASDAQ:WSFS) had its overweight rating reaffirmed by analysts at Stephens. The firm currently has a $64.00 target price on the stock.

Zions Bancorporation, National Association (NASDAQ:ZION) was upgraded by analysts at Argus from a hold rating to a buy rating. The firm currently has $55.00 price target on the stock.

Zscaler (NASDAQ:ZS) was upgraded by analysts at BNP Paribas from a neutral rating to an outperform rating. The firm currently has $260.00 price target on the stock.